Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariusz Bidzinski

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Ginekologia Polska|January 9, 2023
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancerBeata U Kotowicz, Malgorzata Fuksiewicz, Mariusz Bidzinski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinomaMagdalena Kowalewska, Marek Tomasz Szkoda, Jakub Radziszewski, et al.
Annals of Diagnostic Pathology|September 27, 2014
Uterine tumors resembling ovarian sex cord tumors, a clinicopathologic study of six casesElwira Bakula-Zalewska, Anna Danska-Bidzinska, Magdalena Kowalewska, et al.
Plos One|October 10, 2017
Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patientsBeata Kotowicz, Malgorzata Fuksiewicz, Joanna Jonska-Gmyrek, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Early cervical cancer managed by laparoscopy and conventional surgery: comparison of treatment resultsPiotr Sobiczewski, Mariusz Bidzinski, Pawel Derlatka, et al.
Oncology Letters|September 13, 2012
The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcomaMateusz Bujko, Magdalena Kowalewska, Anna Danska-Bidzinska, et al.
World Journal of Surgical Oncology|March 1, 2016
Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancerPawel Derlatka, Jacek Sienko, Laretta Grabowska-Derlatka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 6, 2013
microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary reportMagdalena Kowalewska, Elwira Bakula-Zalewska, Magdalena Chechlinska, et al.
Frontiers in Oncology|October 17, 2022
Increased diversity of a cervical microbiome associates with cervical cancerNatalia Zeber-Lubecka, Maria Kulecka, Bogusław Lindner, et al.
BMC Cancer|January 31, 2008
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective studyJolanta Kupryjanczyk, Ewa Kraszewska, Izabela Ziolkowska-Seta, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Ginekologia Polska|January 9, 2023
Measurement of HE4 six months after first-line treatment as optimal time in identifying patients at high risk of progression advanced ovarian cancerBeata U Kotowicz, Malgorzata Fuksiewicz, Mariusz Bidzinski, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 9, 2010
The frequency of human papillomavirus infection in polish patients with vulvar squamous cell carcinomaMagdalena Kowalewska, Marek Tomasz Szkoda, Jakub Radziszewski, et al.
Annals of Diagnostic Pathology|September 27, 2014
Uterine tumors resembling ovarian sex cord tumors, a clinicopathologic study of six casesElwira Bakula-Zalewska, Anna Danska-Bidzinska, Magdalena Kowalewska, et al.
Plos One|October 10, 2017
Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patientsBeata Kotowicz, Malgorzata Fuksiewicz, Joanna Jonska-Gmyrek, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 17, 2009
Early cervical cancer managed by laparoscopy and conventional surgery: comparison of treatment resultsPiotr Sobiczewski, Mariusz Bidzinski, Pawel Derlatka, et al.
Oncology Letters|September 13, 2012
The promoter methylation and expression of the O6-methylguanine-DNA methyltransferase gene in uterine sarcoma and carcinosarcomaMateusz Bujko, Magdalena Kowalewska, Anna Danska-Bidzinska, et al.
World Journal of Surgical Oncology|March 1, 2016
Results of optimal debulking surgery with bowel resection in patients with advanced ovarian cancerPawel Derlatka, Jacek Sienko, Laretta Grabowska-Derlatka, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 6, 2013
microRNAs in uterine sarcomas and mixed epithelial-mesenchymal uterine tumors: a preliminary reportMagdalena Kowalewska, Elwira Bakula-Zalewska, Magdalena Chechlinska, et al.
Frontiers in Oncology|October 17, 2022
Increased diversity of a cervical microbiome associates with cervical cancerNatalia Zeber-Lubecka, Maria Kulecka, Bogusław Lindner, et al.
BMC Cancer|January 31, 2008
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective studyJolanta Kupryjanczyk, Ewa Kraszewska, Izabela Ziolkowska-Seta, et al.
Pageof 5